Рекомендуемая литература

HIV drug resistance early warning indicators. World Health Organization indicators to monitor HIV drug resistance prevention at antiretroviral treatment sites, http://apps.who.int/iris/ bitstream/10665/75186/1/9789241503945_eng.pdf?ua=1.

The Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. World Health Organization’s global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 2008;13 Suppl 2:1-13. http://www.who.int/hiv/drugresistance/WHO_HIVDR_strategy.pdf?ua=1.

Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther. 2008; 13 Suppl 2:25-36. http://www.who.int/hiv/drugresistance/WHO_HIVDR_ transmission_survey.pdf?ua=1.

Jordan MR, Bennett DE, Bertagnolio S, Gilks CF, Sutherland D. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites. Antivir Ther. 2008; 13 Suppl 2:15-23. http://www.who.int/hiv/ drugresistance/HIVDR_prev_survey_article.pdf?ua=1.

Bertagnolio S, Derdelinckx I, Parker M, Fitzgibbon J, Fleury FI, Peeters M, Schuurman R, Pillay D, Morris L, Tanuri A, Gershy-Damet GM, Nkengasong J, Gilks CF, Sutherland D, Sandstrom P. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy. Antivir Ther. 2008; 13 Suppl 2:49-57. http://www.who.int/hiv/drugresistance/WHO_HIVDR_ lab_strategy.pdf?ua=1.

WHO/HIVresNet HIV drug resistance laboratory strategy. July, 2010. http://www.who.int/ hiv/pub/drugresistance/hiv_reslab_strategy.pdf?ua=1.

Robert W Shafer, Soo-Yon Rhee and Diane E Bennett. Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies. Antiviral Therapy Volume 13, 2008; Supplement 2: 59-68. http://www.who.int/hiv/drugresistance/selection_of_ mutations_for_transmitted_resistance.pdf?ua=1.

WHO manual for HIV drug resistance testing using dried blood spot specimens. 2012. http://apps.who.int/iris/bitstream/10665/75829/1/WHO_HIV_2012.30_eng.pdf?ua=1.

Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury FI, Kiuchi M, Heneine W, Kantor R, Jordan MR, Schapiro JM, Vandamme AM, Sandstrom P, Boucher CA, van de Vijver D, Rhee SY, Liu TF, Pillay D, Shafer RW. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One. 2009;4(3):e4724. http://www.ncbi. nlm.nih.gov/pmc/articles/PMC2648874/pdf/pone.0004724.pdf.

Frentz D, Boucher CA, van de Vijver DA. Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world. AIDS Rev. 2012 Jan-Mar;14(1):17-27.

 
Посмотреть оригинал
< Пред   СОДЕРЖАНИЕ   ОРИГИНАЛ